Improving the Specificity of Screening for Lethal Prostate Cancer Using Prostate-specific Antigen and a Panel of Kallikrein Markers: A Nested Case–Control Study

BACKGROUND: A disadvantage of prostate-specific antigen (PSA) for the early detection of prostate cancer (PCa) is that many men must be screened, biopsied, and diagnosed to prevent one death. OBJECTIVE: To increase the specificity of screening for lethal PCa at an early stage. DESIGN, SETTING, AND P...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Eur Urol
Hlavní autoři: Stattin, Pär, Vickers, Andrew J., Sjoberg, Daniel D., Johansson, Robert, Granfors, Torvald, Johansson, Mattias, Pettersson, Kim, Scardino, Peter T., Hallmans, Göran, Lilja, Hans
Médium: Artigo
Jazyk:Inglês
Vydáno: 2015
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4496315/
https://ncbi.nlm.nih.gov/pubmed/25682340
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eururo.2015.01.009
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky